To elucidate whether METTL1 inhibition can mount an innate immune response by activating the IFN signalling pathway, we investigated whether METTL1 downregulation could alter cytokine expression and secretion in PCa cells. The gene discussed is IFNA1; the disease is posterior cortical atrophy.